Skip to content
riluzole

Structure via PubChem · Public domain (PubChem)

EntityQ415744· pop 27· linked from 547 articles

Riluzole is a medication used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months. Riluzole is available in tablet and liquid form. A thin film version of riluzole which dissolves on the tongue (commercially known as Exservan or Emylif) is available in the United States and United Kingdom.

Chemical data

Formula
C8H5F3N2OS
Molecular weight
234.2 g/mol
IUPAC name
6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
SMILES
C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
InChIKey
FTALBRSUTCGOEG-UHFFFAOYSA-N
XLogP
3.6
Polar surface area
76.4 Ų
H-bond donors
1
H-bond acceptors
7
Formal charge
0

via PubChem

Research

2,265 papers

via PubMed

~4 min read

Encyclopedic overview

13 sections
Contents
  • Medical uses
  • Amyotrophic lateral sclerosis
  • Contraindications
  • Adverse effects
  • Overdose
  • Interactions
  • Mechanism of action
  • Synthesis
  • Society and culture
  • Legal status
  • Research
  • See also
  • References

Riluzole is a medication used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months. Riluzole is available in tablet and liquid form. A thin film version of riluzole which dissolves on the tongue (commercially known as Exservan or Emylif) is available in the United States and United Kingdom.

==Medical uses==

Excerpted from Wikipedia’s “riluzole” article, available under the CC BY-SA 4.0 licence.

Gallery (3)